Halitosis Treatment Industry Analysis Worldwide 2019 -Global Trends, Size, Analysis, Emerging Factors, Competitive Landscape, Regional Analysis and Forecast to 2023

-

Halitosis Treatment Industry Market Research Report - Global Forecast till 2023 is likely to fuel the market growth of global halitosis treatment market at a CAGR of 18.58% during the forecast period 2018 to 2023

Leading Market Players
Colgate-Palmolive Company (U.S), All USA Partners LLC (U.S), Dr. Harold Katz, LLC (U.S), Rowpar Pharmaceuticals, Inc. (U.S), Abbott (U.S), Listerine (U.S), AstraZeneca (U.S)

Halitosis Treatment Industry Highlights

The halitosis treatment market is getting enough tailwind from several quarters such as chronic & periodontal diseases, and advancement in healthcare technologies. It is a clinical condition that results in unpleasant odor from the mouth and significantly impacts the social life of the patient. Psychological pressure can also trigger this disease. It can be detected by using devices and test such as halimeter, gas chromatography, BANA test, and Beta-galactosidase test. The global halitosis treatment market is expected to reach a valuation of USD 22,153.4 billion by 2023 with a high CAGR of 18.58% during the forecast period (2017-2023), discloses Market Research Future (MRFR). The report further highlights factors such as the availability of a wide range of dental healthcare product, and technological support, along with government initiatives, as potential halitosis treatment market drivers.

Global Halitosis Treatment Market: Segmental Overview

Based on indication the market has been segmented into liver, respiratory, gastrointestinal, kidney, systemic and others. The liver segment is further sub-segmented into gall bladder diseases, liver failure and others. The respiratory segment is further sub-segmented into tuberculosis, pharyngitis, sinusitis, emphysema, pneumonia and others. The gastrointestinal segment is further sub-segmented into stomach cancer, pharyngitis, oesophageal reflux and malabsorption. The kidney segment also covers Uremia. The systemic segment covers diabetes. 

Based on type of halitosis the market has been segmented into pathological halitosis and others. The pathological halitosis segment covers extra oral pathological halitosis, and oral pathological halitosis.
Based on drug treatment the market has been segmented into ranitidine, antiseptic, antacids and other drugs.
Based on diagnostic test the market has been segmented into gas chromatography, β-galactosidase activity assay, halimeter, BANA test and other tests.

Table of Content
4.1 DRIVERS
4.1.1 RISING PREVALENCE OF PERIODONTAL DISEASES
4.1.2 GERIATRIC POPULATION
4.1.3 AVAILABILITY OF WIDE RANGE OF PRODUCTS
4.1.4 INCREASING PREVALENCE OF CHRONIC DISEASES
4.2 RESTRAINTS
4.2.1 LACK OF AWARENESS ABOUT HALITOSIS AND ITS TREATMENT
4.2.2 ALTERNATIVE TREATMENT
4.3 OPPORTUNITIES
4.3.1 TECHNOLOGICAL ADVANCEMENT
4.4 MEGA TRENDS
4.4.1 SHIFT FROM DIAGNOSIS TO MANAGEMENT
4.4.2 NANO SENSOR FOR DISEASE DIAGNOSIS
4.5 MACROECONOMIC INDICATORS
Continued…
Halitosis treatment market information: by type (pathologic halitosis, others), by indication (respiratory, liver, kidney, gastrointestinal, systemic, others), by diagnostic tests (halimeter, gas chromatography, BANA Test, β-galactosidase activity assay, others), by drug treatment (antacids, antiseptics, ranitidine, others) - Global forecast till 2023. For more information on our market research, please visit-@ https://www.marketresearchfuture.com/reports/halitosis-treatment-market-3758
Browse other healthcare-related reports
Oral Thin Film Drugs Market – Global Forecast 2023
Needle-Free Injection Market – Global Forecast 2023
About Market Research Future:
MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
www.marketresearchfuture.com



Comments

Post a Comment

Popular posts from this blog

Insulin Delivery Devices Market Analysis Outlook 2025 By Top Manufactures Size, Trends, Demand and Growth Prospects 2020

-
  Insulin Delivery Devices Market Size, Application and Trends Analysis By Type (Insulin Syringes, Pen, Insulin Pumps, Insulin Jet Injectors, Pen Needles), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales And Diabetes Clinics/ Centers), End User and Region, Forecast Till 2025 The Global  Insulin Delivery Devices Market  size is estimated to grow at a  CAGR of 7.85%  and expected to reach  USD 21,804  Million by 2025, says Market Research Future (MRFR). Insulin, a glucose directing hormone, assumes a fundamental job in the whole treatment of diabetes. Insulin delivery frameworks help in infusing insulin into the greasy tissue under the skin. Factors, such as developing diabetic populace, innovative headways in insulin delivery systems, and favoring repayment arrangements, expanding mindfulness among shoppers on the accessibility of a few delivery devices and advancement of human insulin devices are relied upon to positively a...
Read more

Alpha-1 Antitrypsin Deficiency Treatment Market Overview by revenue and forecast to 2025

-
As of July 2019, 3.4 million people are affected by alpha-1 antitrypsin deficiency worldwide. The disorder is found to affect populations in all the regions of the world. The market is dominated by numerous established players. The key players are involved in product launches, strategic collaborations, and awareness programs to strengthen their market positions. For instance, in November 2018, Grifols S. A. launched the AlfaCare therapy program for training and counseling of patients diagnosed with alpha-1 antitrypsin deficiency. Registering a  CAGR  of  10.50%,  the global  Alpha-1 Antitrypsin Deficiency Treatment Market  is expected to grow from  USD 1,464.1 million  in 2018 to  USD 2,914.7 million  by  2025 . Alpha-1 Antitrypsin Deficiency Treatment   Market-Key Players: Kamada Pharmaceuticals CSL Behring LLC Grifols Takeda Pharmaceutical Company Limited GlaxoSmithKline plc Boehringer Ingelheim GmbH AstraZe...
Read more

Varicocele treatment Market Size Forecast by-product overview and forecast 2023

-
  Varicocele Treatment Market Size by grade (Grade I, Grade II, Grade III, and others), diagnosis (physical exam, imaging test, and others), by treatment (Varicocele repair, Varicocele Embolization, and others), by end user- Global forecast till 2023 The  Varicocele Treatment Market Size  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Varicocele Treatment Market Size Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. Due to the increasing strategic partnerships, the structure of the market is changing rapidly. Following are Some Major P...
Read more